Consumers Union (CU) welcomes the opportunity to comment on the Food and Drug Administration (FDA) Draft Environmental Assessment and Preliminary Finding of No Significant Impact (FONSI) Concerning a Genetically Engineered (GE) Atlantic Salmon. For reasons articulated below, we strongly urge FDA not to approve the application for AquaBounty’s AquAdvantage Salmon (AAS) at this time and should prepare a complete Environmental Impact Statement (EIS). We believe that FDA must prepare a full EIS with the best most up-to-date science for ecological risk assessment that considers all possible grow-out locations, including ones in the USA, and that includes a thorough failure mode analysis.
For full comments, click here.